Böcher S, Gervelmeyer A, Monnet D L, Mølbak K, Skov R L
National Centre for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Clin Microbiol Infect. 2008 Oct;14(10):942-8. doi: 10.1111/j.1469-0691.2008.02055.x. Epub 2008 Aug 26.
The proportion of methicillin-resistant Staphylococcus aureus (MRSA) in Denmark has been below 1% for more than 30 years. However, a marked increase in community-onset MRSA (CO-MRSA) started in 2002. To identify possible risk factors for CO-MRSA infections, a nationwide case-control study was conducted in 2004. Cases (34) were patients with CO-MRSA infections; controls (87) were patients with community-onset methicillin-sensitive S. aureus infections (CO-MSSA). Demographic and clinical data and exposures to possible risk factors during the last 24 months were collected with a structured telephone-administered questionnaire. Skin and soft tissue were the predominant sites of infection, both for cases (68%) and for controls (60%). A large proportion of cases (26%) and controls (38%) had an underlying skin disease. The majority of cases (76%) and controls (61%) had received antibiotics within the last 6 months, and 51% and 31%, respectively, had been hospitalized within the previous year. In a multivariate analysis, non-Danish origin, defined as being from or having parents from outside Denmark, was the only independent risk factor for CO-MRSA infection (OR 30.5, 95% CI 3.6-257.3). Prior hospitalization for >7 days within the previous 6 months tended to be associated with CO-MRSA infection (OR 5.7, 95% CI 0.9-36.4). The predominant MRSA clones found in this study were CC80 (26%), CC8 (24%) and CC5 (18%). Resistance to three or more antimicrobial drug classes was seen in 47% of CO-MRSA isolates. Panton-Valentine leukocidin was found in 47% of CO-MRSA isolates. Apart from a non-Danish origin, CO-MRSA shared the same risk factors as CO-MSSA, which makes control a challenge.
在丹麦,耐甲氧西林金黄色葡萄球菌(MRSA)的比例30多年来一直低于1%。然而,2002年起社区获得性MRSA(CO-MRSA)显著增加。为确定CO-MRSA感染的可能危险因素,2004年开展了一项全国性病例对照研究。病例组(34例)为CO-MRSA感染患者;对照组(87例)为社区获得性甲氧西林敏感金黄色葡萄球菌感染(CO-MSSA)患者。通过结构化电话调查问卷收集过去24个月的人口统计学和临床数据以及可能危险因素的暴露情况。皮肤和软组织是病例组(68%)和对照组(60%)感染的主要部位。很大比例的病例组(26%)和对照组(38%)有潜在皮肤病。大多数病例组(76%)和对照组(61%)在过去6个月内接受过抗生素治疗,且分别有51%和31%在前一年住院。多变量分析中,非丹麦裔(定义为本人或父母来自丹麦境外)是CO-MRSA感染的唯一独立危险因素(比值比30.5,95%可信区间3.6 - 257.3)。前6个月内曾住院>7天与CO-MRSA感染有一定关联(比值比5.7,95%可信区间0.9 - 36.4)。本研究中发现的主要MRSA克隆为CC80(26%)、CC8(24%)和CC5(18%)。47%的CO-MRSA分离株对三种或更多类抗菌药物耐药。47%的CO-MRSA分离株检测到杀白细胞素。除了非丹麦裔外,CO-MRSA与CO-MSSA有相同的危险因素,这给防控带来了挑战。